“Ethical concerns regarding embryonic stem cells is expected to drive the overall growth of the synthetic stem cells market.”The synthetic stem cells market is expected to grow from USD 14 million in 2023 to USD 37 million by 20283, at a CAGR of 22.5% during the forecast period. The synthetic stem cells market is driven by various factors such as ethical concerns regarding embryonic stem cells and the risk of tumor formation and immune rejection of natural stem cells. However, the unclear and unstructured regulations on the use of synthetic stem cells can hinder the growth of the market.
“The neurological disorders segment is expected to witness the highest CAGR during the forecast period.”

The neurological disorders application is the faster-growing segment in the overall synthetic stem cells market. Based on application, the synthetic stem cells market is segmented into cardiovascular diseases, neurological disorders, and other diseases that include various cancers, wounds and injuries, musculoskeletal disorders, and blood disorders that require regenerative therapies.
“North America is expected to record the highest growth rate during the forecast period.”
Countries in North America are constantly modernizing their healthcare infrastructure by investing in advanced therapies. The increasing prevalence of target diseases, focus on development of for regenerative medicines, fast adoption of advanced therapies, and regulatory support for stem cell therapies will result in the high rate of adoption of synthetic stem cell therapies in this region by 2023.
In-depth interviews were conducted with Chief Executive Officers (CEOs), marketing directors, innovation and technology directors, and executives from various key organizations operating in the synthetic stem cells market.

The synthetic stem cells market comprises two major providers, namely, North Carolina State University (NCSU) (US) and Zhengzhou University (China).

Research Coverage:
This market study covers the synthetic stem cells market across various segments. It aims at estimating the market size and the growth potential of this market across different segments based on application and region.
Key Benefits of Buying the Report:
The report will provide the market leaders/new entrants in this market with information on the closest approximations of the revenue of the overall synthetic stem cells market and its subsegments. This report will help stakeholders understand the competitive landscape and gain insights to better position their businesses and plan suitable go-to-market strategies. The report will also help stakeholders to understand the pulse of the market and provide them with information on key market drivers, restraints, challenges, and opportunities.

※関連の医療情報レポート

幹細胞バンクの世界市場：臍帯血バンク、コード組織バンクBT-4447 / MarketsandMarkets / 2016年7月18日 / 当調査レポートでは、幹細胞バンクの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、バンク種類別分析、サービス別分析、用途別分析、地域別分析、市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global stem cell banking market is expected to reach USD 3.96 Billion by 2021 from USD 1.58 Billion in 2016, at a CAGR of 20.2% from 2016 to 2021. Increasing awareness regarding the storage of cord blood and tissue stem cells, high growth potential of emerging economies, and increasing use of stem cells in the field of therapeutics have opened an array of opportunities for the growth of the market in the coming years. The global stem cell banking market is classified on the basis of type into cord blood and cord blood & cord tissue. On the basis...

幹細胞アッセイの世界市場予測（～2023年）MAM-BT-4628 / MarketsandMarkets / 2018年3月28日 / MarketsandMarketsが発行した当調査レポートでは、幹細胞アッセイの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、種類別分析、細胞タイプ別分析、製品別分析、用途別分析、幹細胞アッセイの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global stem cell assay market is expected to reach USD 1,978.7 Million by 2023 from USD 791.9 Million in 2018, at a CAGR of 20.1%. The market growth is primarily driven by increasing government and private funding for stem cell research and technological innovations in stem cell research-based instruments. The global stem cell assay market is segmented by type, cell type, product & service, application, end user, and region. By type, the market is segmented into viability/cytotoxicity, isolation & purification, cell identification, proliferation, differentiation, function, and apoptosis assays. The viability/cytotoxicity segment accounted for the largest market share of the...

幹細胞の世界市場分析：成体幹細胞、hESC、iPS細胞GVIEW70714031 / Grand View Research / 2017年6月15日 / 本調査レポートでは、幹細胞の世界市場について調査・分析し、幹細胞の世界市場動向、幹細胞の世界市場規模、市場予測、セグメント別幹細胞市場分析、主要地域別市場規模、競争状況、関連企業情報などを含め、以下の構成でお届け致します。...The global stem cell market is expected to reach USD 15.63billion by 2025, growing at a CAGR of 9.2%, according to a new report by Grand View Research, Inc. Augmentation in research studies that aim at broadening the utility scope of associated products is anticipated to drive the market growth. These research projects have opened the possibility of implementation of several clinical applications of these cells, thereby impacting disease-modifying treatments. Scientists are engaged in discovering novel methods to create human stem cells. This is to address the increasing demand for stem cell production for potential investigation in disease management. This...

バイオサージェリーの世界市場予測（～2021）：フィブリンシーラント、コラーゲンシーラント、止血鉗子、癒着防止バリア、生物学的メッシュ、軟組織付着、ステープラー、骨移植片MAM-MD-3554 / MarketsandMarkets / 2016年11月30日 / 当調査レポートでは、バイオサージェリーの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、市場シェア分析、製品別分析、用途別分析、地域別分析、バイオサージェリーの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global biosurgery market is expected to reach USD 27.78 Billion by 2021 from USD 18.21 Billion in 2016, at a CAGR of 8.8% during the forecast period of 2016 to 2021. Rising number of surgeries, rising incidences of sports related injuries and spinal problems, increasing clearance of biosurgery products by regulatory authorities, and rising need of effective blood loss management are major factors driving the growth of the market. However, little-to-no reimbursements for biosurgery products, high price of biosurgery products, and rising cost of surgical procedures may restrain the growth of this market to a certain extent. In this...

接着バリアの世界市場予測（～2023年）：再生セルロース、ヒアルロン酸、ポリエチレングリコール、フィブリン、コラーゲン、たんぱく質MD4492 / MarketsandMarkets / 2018年5月21日 / MarketsandMarketsが発行した当調査レポートでは、接着バリアの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、市場シェア分析、製品（再生セルロース、ヒアルロン酸、ポリエチレングリコール、フィブリン、コラーゲン、たんぱく質）別分析、種類別分析、用途別分析、地域別分析、接着バリアの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The adhesion barrier market is projected to reach to USD 806.4 million by 2023 from estimated USD 570.7 million in 2018. Factors such as rising geriatric population, increase in the volume of surgeries and sports related-injuries, and increasing awarness about the medical implications of adhesion are expected to drive the growth of this market during the forecast period of 2018 to 2023. However, reluctance among surgeons towards the usgage of adhesion barriers and the stringent regulations resulting in limited technological innovations may challenge market growth to a certain extent in the coming years. The hyaluronic acid segment is projected to...

幹細胞バンクの世界市場見通し：臍帯血、臍帯組織SMRC611026 / Stratistics MRC / 2016年10月 / 当調査レポートでは、幹細胞バンクの世界市場について調査・分析し、幹細胞バンクの世界市場規模、市場動向、関連企業分析などを含め、以下の構成でお届けいたします。 ・エグゼクティブサマリー ・序文 ・幹細胞バンクの世界市場：市場動向分析 ・幹細胞バンクの世界市場：競争要因分析 ・幹細胞バンクの世界市場：セグメント別分析/市場規模 ・幹細胞バンクの世界市場：地域別分析/市場規模 ・幹細胞バンクの北米市場規模 ・幹細胞バンクの欧州市場規模 ・幹細胞バンクのアジア市場規模...According to Stratistics MRC, the Global Stem Cell Banking Market is accounted for $1.42 billion in 2015 and is expected to reach $4.58 billion by 2022 growing at a CAGR of 18.2% during the forecast period. Growing number of newborns, increasing usage of stem cells in disorder treatment and rising disposable income are some of the factors fueling the market growth. However, huge operating price and regulatory changes are some of the factors hampering the market. Rising awareness about potential use of cord tissue and the automation of procedures are creating opportunities for vendors in the market. Some of the...

幹細胞治療の世界市場予測（～2021年）：同種幹細胞、自己幹細胞MAM-BT5049 / MarketsandMarkets / 2017年2月28日 / 当調査レポートでは、幹細胞治療の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、種類別分析、用途別分析、ソース別分析、地域別分析、幹細胞治療の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global stem cell therapy market is estimated to grow at a CAGR of 11.0% during 2016 to 2021 to reach USD 145.8 million by 2021. Growth in the global stem cell therapy market is driven by factors such as the growing awareness of the therapeutic potency of stem cells in effective disease management, development of advanced genome-based cell analysis techniques, increasing public-private investments for development of stem cell therapies, identification of new stem cell lines, and developments in infrastructure related to stem cell banking and processing. In addition, countries such as Japan, South Korea, and China are offering new...

幹細胞製造の世界市場予測（～2023年）：HSC、MSC、iPSC、ESC、装置、培地、消耗品BT-6089 / MarketsandMarkets / 2018年3月13日 / MarketsandMarketsが発行した当調査レポートでは、幹細胞製造の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、製品別分析、用途別分析、需要先別分析、地域別分析、幹細胞製造の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global stem cell manufacturing market is projected to reach USD 14.61 Billion by 2023 from USD 10.75 Billion in 2018, at a CAGR of 6.3%. Factors such as growing public-private investments and funding in stem cell-based research, rising public awareness regarding about the therapeutic potency of stem cell products, development of advanced genomic analysis techniques for quality control during stem cell manufacturing, technological advancements in stem cell manufacturing and preservation, and evolving regulatory frameworks for stem cell therapeutics in the US and Europe are driving the growth of the market. This report broadly segments the stem cell manufacturing market...

合成生物学（構成生物学）の世界市場予測（～2022年）：ツール、技術、用途、産業MAM-BT-2910 / MarketsandMarkets / 2017年12月6日 / MarketsandMarketsが発行した当調査レポートでは、合成生物学（構成生物学）の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、ツール別分析、技術別分析、用途別分析、地域別分析、合成生物学（構成生物学）の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“The global synthetic biology market is projected to grow at a CAGR of 19.9%. in the next five years”The synthetic biology market is expected to reach USD 8.84 billion by 2022 from an estimated USD 3.57 billion in 2017, at a CAGR of 19.9%. The key factors driving the growth of this market include the wide range of applications of synthetic biology, rising R&D funding and initiatives, increasing demand for synthetic genes and synthetic cells, and increasing investments in synthetic biology companies. On the other hand, possible environmental and security issues related to synthetic biology are likely to restrain the...

シングルユースバイオリアクターの世界市場予測（～2022年）BT-2863 / MarketsandMarkets / 2017年11月28日 / MarketsandMarketsが発行した当調査レポートでは、シングルユースバイオリアクターの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、製品別分析、分子タイプ別分析、細胞タイプ別分析、用途別分析、シングルユースバイオリアクターの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global single-use bioreactors market is projected to reach 2,685.1 Million by 2022 from USD 997.6 Million in 2017, at a CAGR of 21.9%. Single-use bioprocessing, which emerged in the 1970s with the use of vials and pipettes, has transformed significantly over the last decade. Single-use bioprocessing is a rapidly evolving technology used in the development of disposable bioprocessing equipment and accessories to manufacture biopharmaceutical products. These disposable equipment mainly help to reduce costs associated with the sterilization, cleaning, and maintenance of steel-based bioreactor systems and accessories. Increasing adoption of SUBs among small companies and startups and reduced automation complexity...